Health Canadas target timeline for the first review of generic drug submissions is 180 days, which the agency says is shorter than similar international regulators
By enhancing GABA signaling (which is calming) and reducing excessive glutamate activity (which drives excitation), semaglutide may lower the neurobiological 'drive' to seek out alcohol as a reward or coping mechanism
This once daily tablet uses an absorption enhancer to allow the semaglutide peptide to reach systemic circulation intact
MEDVi QUAD is not a substitute for prescribed medical treatment
Additionally, Zepbound (tirzepatide), a dual-action GIP/GLP-1 receptor agonist, targets two hormones to enhance weight loss
By Application Type 2 Diabetes Mellitus occupied the maximum market share in 2025 as a result of established treatment guidelines, reimbursement coverage, and clinical use